These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36209494)
21. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet? Lucantoni F; Martínez-Cerezuela A; Gruevska A; Moragrega ÁB; Víctor VM; Esplugues JV; Blas-García A; Apostolova N J Pathol; 2021 Jul; 254(3):216-228. PubMed ID: 33834482 [TBL] [Abstract][Full Text] [Related]
22. PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway. Xu A; Li Y; Zhao W; Hou F; Li X; Sun L; Chen W; Yang A; Wu S; Zhang B; Yao J; Wang H; Huang J J Mol Med (Berl); 2018 Feb; 96(2):119-133. PubMed ID: 29098317 [TBL] [Abstract][Full Text] [Related]
23. Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1. Lan T; Zhuang L; Li S; Yang G; Xuan Y; Guo J Biomed Pharmacother; 2020 Oct; 130():110586. PubMed ID: 34321171 [TBL] [Abstract][Full Text] [Related]
24. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice. Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997 [TBL] [Abstract][Full Text] [Related]
25. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway. Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499 [TBL] [Abstract][Full Text] [Related]
26. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552 [TBL] [Abstract][Full Text] [Related]
27. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581 [TBL] [Abstract][Full Text] [Related]
28. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl He C; Shu B; Zhou Y; Zhang R; Yang X Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896 [TBL] [Abstract][Full Text] [Related]
29. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice. Choi S; Jung HJ; Kim MW; Kang JH; Shin D; Jang YS; Yoon YS; Oh SH Biochem Biophys Res Commun; 2019 May; 513(1):49-55. PubMed ID: 30935693 [TBL] [Abstract][Full Text] [Related]
30. Resveratrol inhibits hepatic stellate cell activation by regulating autophagy and apoptosis through the SIRT1 and JNK signaling pathways. Zhang J; Ping J; Jiang N; Xu L J Food Biochem; 2022 Dec; 46(12):e14463. PubMed ID: 36314441 [TBL] [Abstract][Full Text] [Related]
31. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. Zhang CY; Yuan WG; He P; Lei JH; Wang CX World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803 [TBL] [Abstract][Full Text] [Related]
32. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells. Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112 [TBL] [Abstract][Full Text] [Related]
33. Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells. Kumar P; Smith T; Raeman R; Chopyk DM; Brink H; Liu Y; Sulchek T; Anania FA J Biol Chem; 2018 Aug; 293(33):12781-12792. PubMed ID: 29941453 [TBL] [Abstract][Full Text] [Related]
34. Neddylation of EphB1 Regulates Its Activity and Associates with Liver Fibrosis. Li R; Zhang D; Han Y; Chen K; Guo W; Chen Y; Wang S Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834826 [TBL] [Abstract][Full Text] [Related]
35. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis. El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860 [TBL] [Abstract][Full Text] [Related]
36. Hepatic stellate cells as key target in liver fibrosis. Higashi T; Friedman SL; Hoshida Y Adv Drug Deliv Rev; 2017 Nov; 121():27-42. PubMed ID: 28506744 [TBL] [Abstract][Full Text] [Related]
37. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential. Kong D; Zhang F; Zhang Z; Lu Y; Zheng S Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010 [TBL] [Abstract][Full Text] [Related]
38. Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis. Xu WH; Hu HG; Tian Y; Wang SZ; Li J; Li JZ; Deng X; Qian H; Qiu L; Hu ZL; Wu QY; Chai YF; Guo C; Xie WF; Zhang JP Hepatology; 2014 Aug; 60(2):648-60. PubMed ID: 24668691 [TBL] [Abstract][Full Text] [Related]